Medium materiality6/10
Climb Bio price target raised to $24 from $20 at H.C. Wainwright
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
CLYM price target raised to $24 from $20; current price $17.28. PriceChangeSinceSignal: -5.09%.
- Target: $24; Price: $17.28
- Price change since signal: -5.09%
- Analyst: H.C. Wainwright
Key facts
- 01
Target: $24
- 02
Posted price: $17.28
- 03
Analyst firm: H.C. Wainwright
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.